Equities

CareRay Digital Medical Technology Co Ltd

688607:SHH

CareRay Digital Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)15.00
  • Today's Change-0.25 / -1.64%
  • Shares traded2.08m
  • 1 Year change-26.97%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year CareRay Digital Medical Technology Co Ltd grew revenues 33.81% from 204.57m to 273.74m while net income improved from a loss of 5.62m to a gain of 15.41m.
Gross margin42.76%
Net profit margin8.55%
Operating margin8.87%
Return on assets2.62%
Return on equity2.90%
Return on investment2.85%
More ▼

Cash flow in CNYView more

In 2023, CareRay Digital Medical Technology Co Ltd increased its cash reserves by 22.15%, or 43.92m. Cash Flow from Investing totalled 22.42m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 21.48m in cash from operations while cash used for financing totalled 601.19k.
Cash flow per share--
Price/Cash flow per share--
Book value per share9.69
Tangible book value per share9.65
More ▼

Balance sheet in CNYView more

CareRay Digital Medical Technology Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio7.95
Quick ratio6.76
Total debt/total equity0.0229
Total debt/total capital0.0224
More ▼

Growth rates in CNY

Year on year, growth in earnings per share excluding extraordinary items increased 374.06%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)19.11%
EPS growth(5 years)-25.18
EPS (TTM) vs
TTM 1 year ago
1,825.38
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.